Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director departure
|
|
INFINITY PHARMACEUTICALS, INC. (INFI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| EVNIN ANTHONY B (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 46,378 shares
@ $0.679, valued at
$31.5k
Granted 45,000 options to buy
@ $0.679, valued at
$30.6k
|
|
| 06/16/2022 |
4
| BEIER DAVID W (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $0.679, valued at
$30.6k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| SELBY NORMAN C (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $0.679, valued at
$30.6k
Granted 10,000 options to buy
@ $0.679, valued at
$6.8k
|
|
| 06/16/2022 |
4
| SCHWARTZ BRIAN (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 30,919 shares
@ $0.679, valued at
$21k
Granted 45,000 options to buy
@ $0.679, valued at
$30.6k
|
|
| 03/31/2022 |
4
| KANGO SUJAY (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 90,000 options to buy
@ $1.13, valued at
$101.7k
|
|
| 01/12/2022 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 576,100 options to buy
@ $1.53, valued at
$881.4k
|
|
| 01/12/2022 |
4
| BLOCH LAWRENCE E (President) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 335,000 options to buy
@ $1.53, valued at
$512.6k
|
|
| 01/12/2022 |
4
| Tasker Seth A (Chief Business Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 225,000 options to buy
@ $1.53, valued at
$344.3k
|
|
| 01/12/2022 |
4
| Peluso Stephane (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 87,027 options to buy
@ $1.53, valued at
$133.2k
|
|
| 01/12/2022 |
4
| Ilaria Robert Jr. (Chief Medical Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 87,472 options to buy
@ $1.53, valued at
$133.8k
|
|
| 09/10/2021 |
4
| SCHWARTZ BRIAN (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 options to buy
@ $3.75, valued at
$225k
|
|
| 09/03/2021 |
4
| Ilaria Robert Jr. (Chief Medical Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 300,000 options to buy
@ $3.59, valued at
$1.1M
|
|
| 08/03/2021 |
4
| Peluso Stephane (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 options to buy
@ $2.93, valued at
$732.5k
Granted 50,000 restricted stock units
@ $0 |
|
| 06/11/2021 |
4
| BEIER DAVID W (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 3,061 shares
@ $3.43, valued at
$10.5k
Granted 30,000 options to buy
@ $3.43, valued at
$102.9k
|
|
| 06/11/2021 |
4
| Agresta Samuel (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.43, valued at
$102.9k
|
|
| 06/11/2021 |
4
| SELBY NORMAN C (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.43, valued at
$102.9k
Granted 10,000 options to buy
@ $3.43, valued at
$34.3k
|
|
| 06/11/2021 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $3.43, valued at
$102.9k
|
|
| 06/11/2021 |
4
| EVNIN ANTHONY B (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 3,061 shares
@ $3.43, valued at
$10.5k
Granted 30,000 options to buy
@ $3.43, valued at
$102.9k
|
|
| 05/18/2021 |
4
| SELBY NORMAN C (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Exercised 5,000 options to buy
@ $0.92, valued at
$4.6k
|
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Sold 2,821,663 shares
@ $4.1388, valued at
$11.7M
Sold 2,458,838 shares
@ $4.1388, valued at
$10.2M
Sold 568,019 shares
@ $4.1388, valued at
$2.4M
|
|
| 12/23/2020 |
4
| Tasker Seth A (Chief Business Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 250,000 options to buy
@ $2.14, valued at
$535k
|
|
| 12/23/2020 |
4
| BLOCH LAWRENCE E (President) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 335,000 options to buy
@ $2.14, valued at
$716.9k
|
|
| 12/23/2020 |
4
| Perkins Adelene Q (CEO) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 485,000 options to buy
@ $2.14, valued at
$1M
|
|
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
4
| GAYNOR RICHARD (Director) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 options to buy
@ $0 |
|
|
|
|